STRS Ohio’s United Therapeutics UTHR Stock Holding History

STRS Ohio’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17M	Buy	31,411 +3,797	+14%	+$2.14M	0.06%	292
2026 Q1	$16.4M	Buy	27,614 +11,198	+68%	+$5.58M	0.07%	302
2025 Q4	$8M	Buy	16,416 +6,354	+63%	+$2.96M	0.03%	427
2025 Q3	$4.22M	Buy	10,062 +9,000	+847%	+$3.03M	0.02%	508
2025 Q2	$305K	Buy	+1,062	New	+$317K	﹤0.01%	1502
2019 Q2	–	Sell	-492	Closed	-$57K	–	2209
2019 Q1	$57K	Hold	492	–	–	﹤0.01%	1865
2018 Q4	$53K	Hold	492	–	–	﹤0.01%	1874
2018 Q3	$62K	Hold	492	–	–	﹤0.01%	1922
2018 Q2	$55K	Hold	492	–	–	﹤0.01%	1965
2018 Q1	$55K	Sell	492 -16	-3%	-$2.03K	﹤0.01%	1725
2017 Q4	$75K	Sell	508 -111	-18%	-$14.1K	﹤0.01%	1681
2017 Q3	$72K	Hold	619	–	–	﹤0.01%	1714
2017 Q2	$80K	Hold	619	–	–	﹤0.01%	1689
2017 Q1	$83K	Hold	619	–	–	﹤0.01%	1700
2016 Q4	$88K	Buy	+619	New	+$79K	﹤0.01%	1683
2016 Q2	–	Sell	-976	Closed	-$108K	–	2013
2016 Q1	$108K	Buy	976 +61	+7%	+$7.72K	﹤0.01%	1643
2015 Q4	$143K	Buy	915 +121	+15%	+$17.6K	﹤0.01%	1592
2015 Q3	$104K	Buy	+794	New	+$127K	﹤0.01%	1654

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

STRS Ohio's UTHR Position: Q2 2026 in Review

STRS Ohio increased its United Therapeutics (UTHR) stake by 14% in Q2 2026, buying an estimated $2.14M and bringing the position to 31,411 shares worth $17M. The position accounts for 0.06% of the portfolio, ranked #292.

STRS Ohio first reported a position in UTHR in Q3 2015 and has held it in 18 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

STRS Ohio held 31,411 shares of United Therapeutics worth $17M as of Q2 2026.
STRS Ohio bought 3,797 United Therapeutics shares in Q2 2026, an estimated $2.14M.
United Therapeutics made up 0.06% of STRS Ohio's portfolio in Q2 2026, its #292 holding.
STRS Ohio first reported a position in United Therapeutics in Q3 2015 and has held it in 18 quarters since.
880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.